Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis

Mismatch negativity (MMN) as a tool for translational investigations into early psychosis: A review

(2019) Mariko Tada et al.   INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY

Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis

(2017) Kingo Sawada et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity

(2017) Minah Kim et al.   SCHIZOPHRENIA BULLETIN

Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis

(2017) Daisuke Koshiyama et al.   SCHIZOPHRENIA RESEARCH

Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis

(2017) Tatsuya Nagai et al.   Scientific Reports

Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia

(2017) Michael L. Thomas et al.   JAMA Psychiatry

Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis

(2017) Daisuke Koshiyama et al.   SCHIZOPHRENIA RESEARCH

A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression

(2016) Molly A. Erickson et al.   BIOLOGICAL PSYCHIATRY

The effects of ketamine on the mismatch negativity (MMN) in humans – A meta-analysis

(2016) Timm Rosburg et al.   CLINICAL NEUROPHYSIOLOGY

Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience

(2016) Sanne de Wit et al.   NeuroImage-Clinical

Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia

(2015) Gregory A. Light et al.   Annals of the New York Academy of Sciences

Forecasting Psychosis by Event-Related Potentials—Systematic Review and Specific Meta-Analysis

(2015) Mitja Bodatsch et al.   BIOLOGICAL PSYCHIATRY

Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis

(2015) Paolo Fusar-Poli et al.   BRITISH JOURNAL OF PSYCHIATRY

Psychotropic dose equivalence in Japan

(2015) Toshiya Inada et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis

(2015) Ricardo E. Carrión et al.   SCHIZOPHRENIA RESEARCH

Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis

(2014) Matti Penttilä et al.   BRITISH JOURNAL OF PSYCHIATRY

Temporo-frontal phase synchronization supports hierarchical network for mismatch negativity

(2014) Shannon E. MacLean et al.   CLINICAL NEUROPHYSIOLOGY

Adolescents at ultra-high risk for psychosis: Long-term outcome of individuals who recover from their at-risk state

(2014) S. de Wit et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Impaired mismatch negativity is associated with current functional status rather than genetic vulnerability to schizophrenia

(2014) Minah Kim et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Symptomatic and functional remission of subjects at clinical high risk for psychosis: A 2-year naturalistic observational study

(2014) Tae Young Lee et al.   SCHIZOPHRENIA RESEARCH

Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia

(2014) Anthony J. Rissling et al.   NeuroImage-Clinical

Mismatch Negativity and Cognitive Performance for the Prediction of Psychosis in Subjects with At-Risk Mental State

(2013) Yuko Higuchi et al.   PLoS One

LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia

(2013) Tomohiro Miyanishi et al.   PLoS One

Moving beyond transition outcomes: Meta-analysis of remission rates in individuals at high clinical risk for psychosis

(2013) Andor E. Simon et al.   PSYCHIATRY RESEARCH

Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis

(2013) Tatsuya Nagai et al.   SCHIZOPHRENIA RESEARCH

Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis

(2013) Ricardo E. Carrión et al.   JAMA Psychiatry

Mismatch Negativity as a “Translatable” Brain Marker Toward Early Intervention for Psychosis: A Review

(2013) Tatsuya Nagai et al.   Frontiers in Psychiatry

Predicting Psychosis

(2012) Paolo Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Cognitive Functioning in Prodromal Psychosis

(2012) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Disentangling early sensory information processing deficits in schizophrenia

(2012) Anthony J. Rissling et al.   CLINICAL NEUROPHYSIOLOGY

A multimodal approach to investigate biomarkers for psychosis in a clinical setting: The integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project

(2012) Shinsuke Koike et al.   SCHIZOPHRENIA RESEARCH

Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis

(2011) Ricardo E. Carrión et al.   AMERICAN JOURNAL OF PSYCHIATRY

At Clinical High Risk for Psychosis: Outcome for Nonconverters

(2011) Jean Addington et al.   AMERICAN JOURNAL OF PSYCHIATRY

The mismatch negativity: A review of underlying mechanisms

(2009) Marta I. Garrido et al.   CLINICAL NEUROPHYSIOLOGY

Gray Matter Deficits, Mismatch Negativity, and Outcomes in Schizophrenia

(2009) P. E. Rasser et al.   SCHIZOPHRENIA BULLETIN

Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia

(2007) Atsuhito Toyomaki et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY